NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 389 filers reported holding NOVAVAX INC in Q1 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,803,429 | -35.6% | 387,214 | -34.0% | 0.00% | 0.0% |
Q2 2023 | $4,356,321 | +6.8% | 586,315 | -0.4% | 0.00% | -50.0% |
Q1 2023 | $4,078,465 | +8.2% | 588,523 | +60.5% | 0.00% | 0.0% |
Q4 2022 | $3,769,902 | +207.5% | 366,722 | +444.4% | 0.00% | +100.0% |
Q3 2022 | $1,226,000 | -92.2% | 67,364 | -78.0% | 0.00% | -85.7% |
Q2 2022 | $15,727,000 | -90.7% | 305,791 | -86.6% | 0.01% | -87.0% |
Q1 2022 | $168,555,000 | -60.2% | 2,288,598 | -22.7% | 0.05% | -61.4% |
Q4 2021 | $423,400,000 | -10.7% | 2,959,390 | +29.3% | 0.14% | -16.7% |
Q3 2021 | $474,326,000 | +20.5% | 2,288,003 | +23.4% | 0.17% | +9.8% |
Q2 2021 | $393,700,000 | +92.4% | 1,854,363 | +64.3% | 0.15% | +50.0% |
Q1 2021 | $204,673,000 | +79.1% | 1,128,857 | +10.1% | 0.10% | +75.9% |
Q4 2020 | $114,292,000 | -27.2% | 1,024,947 | -29.3% | 0.06% | -38.3% |
Q3 2020 | $156,975,000 | +36.9% | 1,448,771 | +5.3% | 0.09% | +9.3% |
Q2 2020 | $114,660,000 | +3790.7% | 1,375,648 | +533.7% | 0.09% | +2766.7% |
Q1 2020 | $2,947,000 | – | 217,087 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |